Loading...
XLONSIS
Market cap74mUSD
Jan 02, Last price  
27.00GBP
1D
0.00%
1Q
4.00%
Jan 2017
-63.89%
IPO
-58.06%
Name

Science in Sport PLC

Chart & Performance

D1W1MN
XLON:SIS chart
P/E
—
P/S
99.19
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
18.96%
Rev. gr., 5y
24.07%
Revenues
63m
-1.73%
4,633,3185,522,2406,846,8098,461,5009,446,00012,243,00015,615,00021,318,00050,573,00050,351,00062,539,00063,773,00062,671,000
Net income
-11m
L+3.38%
109,673-97,238-958,572-1,291,000-1,509,000-2,644,000-3,606,000-5,875,000-5,618,000-1,728,000-6,817,000-10,910,000-11,279,000
CFO
3m
P
232,91785,840-1,305,276-667,500-859,000-1,611,000-2,526,000-6,421,000-80,0003,144,000-162,000-8,649,0003,249,000
Earnings
Jun 26, 2025

Profile

Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; supplements; and vitamins. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains; specialist sports retailers; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as phd.com and scienceinsport.com digital platforms, third-party online sites in the United Kingdom, rest of Europe, the United States, and internationally. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.
URL
http://www.scienceinsport.com/us/about
IPO date
Aug 09, 2013
Employees
229
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
62,671
-1.73%
63,773
1.97%
Cost of revenue
66,994
68,773
Unusual Expense (Income)
NOPBT
(4,323)
(5,000)
NOPBT Margin
Operating Taxes
(12)
332
Tax Rate
NOPAT
(4,311)
(5,332)
Net income
(11,279)
3.38%
(10,910)
60.04%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,000
BB yield
-25.72%
Debt
Debt current
11,664
8,594
Long-term debt
22,959
24,020
Deferred revenue
Other long-term liabilities
1,059
Net debt
32,479
31,684
Cash flow
Cash from operating activities
3,249
(8,649)
CAPEX
(1,103)
(7,954)
Cash from investing activities
(2,112)
(7,954)
Cash from financing activities
324
12,683
FCF
1,035
(14,513)
Balance
Cash
2,144
930
Long term investments
Excess cash
Stockholders' equity
(22,873)
(11,369)
Invested Capital
76,847
72,906
ROIC
ROCE
EV
Common stock shares outstanding
170,124
138,860
Price
0.12
-16.07%
0.14
-79.56%
Market cap
19,990
2.82%
19,440
-78.74%
EV
52,469
52,169
EBITDA
1,927
(192)
EV/EBITDA
27.23
Interest
1,558
757
Interest/NOPBT